|
Status |
Public on Jun 18, 2013 |
Title |
WholeBloodRNA_IN0366_Day3 |
Sample type |
RNA |
|
|
Source name |
Whole blood
|
Organism |
Homo sapiens |
Characteristics |
gender: female tissue: whole blood subject: IN0366 time: Day3 treatment: trivalent influenza vaccination
|
Growth protocol |
For each sample, 2.5 mL whole blood was collected directly into PAXgene RNA Stabilization Tubes (QIAGEN), mixed by inverting, incubated at room temperature for at least 2 hours, then frozen at -80C until the time of purification
|
Extracted molecule |
total RNA |
Extraction protocol |
RNA was extracted with the QIAGEN PAXgene Blood RNA System, in accordance with the protocol provided with the kit. Quality control was performed on a BioRad Experion microfluidic electrophoresis system
|
Label |
biotin
|
Label protocol |
Biotinylated cRNA was prepared with the Ambion Illumina TotalPrep RNA Amplification Kit
|
|
|
Hybridization protocol |
Standard Illumina hybridization protocol
|
Scan protocol |
Standard Illumina scanning protocol. Scanning was performed on an Illumina iScan system
|
Data processing |
Raw data underwent background adjustment, variance stabilization transformation, and robust spline normalization using R package lumi (available from Bioconductor) and function lumiExpresso() The data normalized by background adjustment, variance stabilization transformation, and robust spline normalization in R package lumi
|
|
|
Submission date |
Jun 17, 2013 |
Last update date |
Dec 03, 2013 |
Contact name |
Luis M Franco |
Organization name |
National Institutes of Health
|
Department |
National Institute of Allergy and Infectious Diseases
|
Lab |
Laboratory of Immune System Biology
|
Street address |
9000 Rockville Pike
|
City |
Bethesda |
State/province |
MD |
ZIP/Postal code |
20892 |
Country |
USA |
|
|
Platform ID |
GPL10558 |
Series (2) |
GSE48023 |
Time series of global gene expression after trivalent influenza vaccination in humans (female cohort) |
GSE48024 |
Time series of global gene expression after trivalent influenza vaccination in humans |
|